Abstract

Background: Recent studies in embryonic mice demonstrate that mitochondrial maturation and cardiac myocyte differentiation are linked. Closure of the mitochondrial permeability transition pore (mPTP), by pharmacologically or genetically manipulating Cyclophilin D (CyPD), drives this process of differentiation. Myocytes in the neonatal heart are relatively immature, but the effects of mPTP closure have not been determined at this developmental stage.Objective: We hypothesized that closure of the mPTP in the neonatal mouse heart will increase cardiac function by increasing mitochondrial maturation and enhancing cardiac myocyte differentiation.Methods: In vitro: Cardiac myocytes cultured from the ventricles of 1-day old wild type (WT) or CyPD null mice were treated with Vehicle (Veh), 500nM Cyclosporin A (CsA), or 500nM NIM811 for 5 days. Assays to determine mitochondrial maturation, both structure and function, and cardiac myocyte differentiation were performed. In vivo: One day old WT or CyPD null mice were treated with daily intraperitoneal injections of Veh, or 10mg/kg of CsA or NIM811 for 5 days. Hearts were processed then analyzed for changes in ventricular wall thickness.Results: In vitro: WT neonatal cardiac myocytes treated with either CsA or NIM811 had more complex mitochondrial structure (P < 0.05), higher mitochondrial membrane potential (NIM811, P <0.01), and more differentiated cardiac myocytes relative to Veh (p<0.05). Deleting CyPD to close the mPTP also increased mitochondrial maturation and myocyte differentiation. In vivo: WT mice hearts treated with NIM811 had thicker left ventricular walls relative to Veh (P < 0.01).Conclusion: Closure of the mPTP using pharmacologic or genetic approaches increased mitochondrial maturation and cardiac myocyte differentiation in cultured neonatal myocytes. Early in vivo experiments demonstrate that mPTP closure in the neonatal heart increased LV wall, suggesting altered myocyte proliferation or differentiation.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.